8-K Announcements
6Material company update
Mar 20, 2026·SEC
Material company update
Mar 19, 2026·SEC
Material company update
Mar 12, 2026·SEC
Aveanna Healthcare Holdings Inc.(AVAH)Earnings, Financials & Key Ratios
AVAH•NASDAQ
$6.76
$1.43B mkt cap·6.4× P/E·Price updated May 6, 2026
AboutAveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.Show more
- Revenue$2.43B+20.2%
- EBITDA$289M+69.1%
- Net Income$225M+2159.1%
- EPS (Diluted)1.05+1951.9%
- Gross Margin33.09%+5.4%
- EBITDA Margin11.88%+40.7%
- Operating Margin10.91%+58.0%
- Net Margin9.25%+1813.3%
- ROE621.89%
- ROIC15.08%+88.6%
- Debt/Equity6.91
- Interest Coverage1.89+112.2%
AVAH Key Insights
Aveanna Healthcare Holdings Inc. (AVAH) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Excellent 3Y average ROE of 621.9%
- ✓Strong 5Y sales CAGR of 10.2%
- ✓Efficient asset utilization: 1.2x turnover
✗Weaknesses
- ✗High debt to equity ratio of 6.9x
- ✗Shares diluted 11.4% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
AVAH Price & Volume
Aveanna Healthcare Holdings Inc. (AVAH) stock price & volume — 10-year historical chart
Loading chart...
AVAH Growth Metrics
Aveanna Healthcare Holdings Inc. (AVAH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years10.23%
3 Years10.82%
TTM20.19%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM2159.05%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM1653.33%
Return on Capital
10 Years-0.53%
5 Years-1.95%
3 Years10.11%
Last Year18.63%
AVAH Recent Earnings
Aveanna Healthcare Holdings Inc. (AVAH) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 11/12 qtrs (92%)
Q2 2026Latest
Mar 19, 2026EPS
$0.17
Est $0.15
+10.5%
Revenue
$662M
Est $643M
+3.0%
Q4 2025
Nov 6, 2025EPS
$0.15
Est $0.08
+87.5%
Revenue
$622M
Est $649M
-4.2%
Q3 2025
Aug 7, 2025EPS
$0.18
Est $0.04
+350.0%
Revenue
$590M
Est $540M
+9.1%
Q2 2025
May 8, 2025EPS
$0.10
Est $0.03
+216.8%
Revenue
$559M
Est $527M
+6.1%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 19, 2026 | $0.17vs $0.15+10.5% | $662Mvs $643M+3.0% |
| Q4 2025 | Nov 6, 2025 | $0.15vs $0.08+87.5% | $622Mvs $649M-4.2% |
| Q3 2025 | Aug 7, 2025 | $0.18vs $0.04+350.0% | $590Mvs $540M+9.1% |
| Q2 2025 | May 8, 2025 | $0.10vs $0.03+216.8% | $559Mvs $527M+6.1% |
Based on last 12 quarters of dataView full earnings history →
AVAH Peer Comparison
Aveanna Healthcare Holdings Inc. (AVAH) competitors in Home-based care services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 PNTG | 1.13B | 32.53 | 38.73 | 36.31% | 2.96% | 8.42% | 1.21 | |
 ADUS | 1.8B | 96.64 | 18.55 | 23.21% | 6.89% | 9.34% | 0.19 | |
 HCSG | 1.58B | 22.07 | 27.25 | 7.08% | 3.21% | 11.83% | 0.05 | |
 ENSG | 10.28B | 175.93 | 30.13 | 18.72% | 6.89% | 16.61% | 1.86 | |
 MMS | 3.49B | 63.95 | 11.61 | 2.36% | 6.92% | 21.62% | 0.86 | |
 OPCH | 3.2B | 20.45 | 16.10 | 13.03% | 3.64% | 15.28% | ||
 BFAM | 3.63B | 66.36 | 19.75 | 9.22% | 7.61% | 17.08% | 1.31 | |
 UNH | 333.37B | 367.28 | 27.76 | 11.81% | 2.68% | 11.54% | 0.77 |
Compare AVAH vs Peers
Aveanna Healthcare Holdings Inc. (AVAH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
AVAH Income Statement
Aveanna Healthcare Holdings Inc. (AVAH) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Jan'26 |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 1.25B | 1.38B | 1.5B | 1.68B | 1.79B | 1.9B | 2.02B | 2.43B |
| Revenue Growth % | - | 10.4% | 8.02% | 12.27% | 6.49% | 6.02% | 6.82% | 20.19% |
| Cost of Goods Sold | 859.35M | 964.81M | 1.04B | 1.14B | 1.23B | 1.3B | 1.39B | 1.63B |
| COGS % of Revenue | 68.55% | 69.71% | 69.6% | 67.69% | 69.05% | 68.58% | 68.61% | 66.91% |
| Gross Profit | 394.32M▲ 0% | 419.25M▲ 6.3% | 454.51M▲ 8.4% | 542.4M▲ 19.3% | 553.23M▲ 2.0% | 595.43M▲ 7.6% | 635.54M▲ 6.7% | 805.15M▲ 26.7% |
| Gross Margin % | 31.45% | 30.29% | 30.4% | 32.31% | 30.95% | 31.42% | 31.39% | 33.09% |
| Gross Profit Growth % | - | 6.32% | 8.41% | 19.34% | 2% | 7.63% | 6.74% | 26.69% |
| Operating Expenses | 339.71M | 380.3M | 458M | 578.51M | 1.2B | 587.36M | 495.75M | 539.77M |
| OpEx % of Revenue | 27.1% | 27.48% | 30.63% | 34.46% | 66.88% | 30.99% | 24.49% | 22.18% |
| Selling, General & Admin | 321.84M | 341M | 354.77M | 419.64M | 483.95M | 464.74M | 470.47M | 526.74M |
| SG&A % of Revenue | 25.67% | 24.64% | 23.73% | 25% | 27.07% | 24.52% | 23.24% | 21.65% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -13.74M | 39.3M | 103.23M | 158.88M | 711.56M | 122.62M | 25.28M | 13.04M |
| Operating Income | 39.03M▲ 0% | 38.95M▼ 0.2% | -3.49M▼ 109.0% | -36.11M▼ 935.6% | -642.28M▼ 1678.6% | 8.07M▲ 101.3% | 139.79M▲ 1631.8% | 265.38M▲ 89.8% |
| Operating Margin % | 3.11% | 2.81% | -0.23% | -2.15% | -35.93% | 0.43% | 6.9% | 10.91% |
| Operating Income Growth % | - | -0.2% | -108.95% | -935.59% | -1678.62% | 101.26% | 1631.75% | 89.85% |
| EBITDA | 50.97M | 65.97M | 26.74M | -722K | -603.46M | 38.17M | 170.95M | 289.15M |
| EBITDA Margin % | 4.07% | 4.77% | 1.79% | -0.04% | -33.76% | 2.01% | 8.44% | 11.88% |
| EBITDA Growth % | - | 29.42% | -59.47% | -102.7% | -83481.72% | 106.33% | 347.86% | 69.14% |
| D&A (Non-Cash Add-back) | 11.94M | 27.01M | 30.22M | 35.39M | 38.82M | 30.1M | 31.16M | 23.77M |
| EBIT | 25.88M | 17.27M | 31.25M | -53.34M | -563.87M | 9.07M | 156.21M | 250.8M |
| Net Interest Income | -74.95M | -92.09M | -82.64M | -68.68M | -107.04M | -152.92M | -156.1M | -137.25M |
| Interest Income | 594K | 207K | 345K | 253K | 679K | 327K | 498K | 2.83M |
| Interest Expense | 75.54M | 92.3M | 82.98M | 68.93M | 107.72M | 153.25M | 156.6M | 140.09M |
| Other Income/Expense | -88.69M | -113.98M | -48.25M | -77.47M | -21.54M | -147.07M | -134.72M | -158.43M |
| Pretax Income | -49.66M▲ 0% | -75.03M▼ 51.1% | -51.73M▲ 31.0% | -113.58M▼ 119.5% | -663.81M▼ 484.5% | -139M▲ 79.1% | 5.07M▲ 103.6% | 106.95M▲ 2008.6% |
| Pretax Margin % | -3.96% | -5.42% | -3.46% | -6.77% | -37.13% | -7.33% | 0.25% | 4.4% |
| Income Tax | -2.51M | 1.49M | 5.32M | 3.47M | -1.78M | -4.47M | 16M | -118.09M |
| Effective Tax Rate % | 5.06% | -1.98% | -10.28% | -3.05% | 0.27% | 3.22% | 315.48% | -110.41% |
| Net Income | -47.15M▲ 0% | -76.52M▼ 62.3% | -57.05M▲ 25.4% | -117.04M▼ 105.2% | -662.03M▼ 465.6% | -134.52M▲ 79.7% | -10.93M▲ 91.9% | 225.03M▲ 2159.1% |
| Net Margin % | -3.76% | -5.53% | -3.82% | -6.97% | -37.03% | -7.1% | -0.54% | 9.25% |
| Net Income Growth % | - | -62.3% | 25.44% | -105.16% | -465.63% | 79.68% | 91.88% | 2159.05% |
| Net Income (Continuing) | -47.15M | -76.52M | -57.05M | -117.04M | -662.03M | -134.52M | -10.93M | 225.03M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.26▲ 0% | -0.41▼ 57.7% | -0.31▲ 24.4% | -0.63▼ 103.2% | -3.57▼ 466.7% | -0.71▲ 80.1% | -0.06▲ 92.0% | 1.05▲ 1951.9% |
| EPS Growth % | - | -57.69% | 24.39% | -103.23% | -466.67% | 80.11% | 92.01% | 1951.85% |
| EPS (Basic) | -0.26 | -0.41 | -0.31 | -0.63 | -3.57 | -0.71 | -0.06 | 1.10 |
| Diluted Shares Outstanding | 180.16M | 185.9M | 185.9M | 184.73M | 185.55M | 189.96M | 192.89M | 214.98M |
| Basic Shares Outstanding | 180.16M | 185.9M | 185.9M | 184.73M | 185.55M | 189.96M | 192.89M | 203.53M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
AVAH Balance Sheet
Aveanna Healthcare Holdings Inc. (AVAH) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Jan'26 |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 214.93M | 186.34M | 340.64M | 279.21M | 269.75M | 314.89M | 392.67M | 560.23M |
| Cash & Short-Term Investments | 8M | 3.33M | 137.34M | 30.49M | 19.22M | 43.94M | 84.29M | 193.26M |
| Cash Only | 8M | 3.33M | 137.34M | 30.49M | 19.22M | 43.94M | 84.29M | 193.26M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 182.45M | 164.3M | 180.88M | 225.29M | 225.63M | 245.81M | 277.66M | 313.36M |
| Days Sales Outstanding | 53.12 | 43.33 | 44.16 | 48.99 | 46.07 | 47.34 | 50.06 | 47.01 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - |
| Other Current Assets | 14.99M | 8.56M | 11.34M | 9.2M | 9.81M | 9.45M | 13.25M | 53.61M |
| Total Non-Current Assets | 1.34B | 1.39B | 1.5B | 2.06B | 1.44B | 1.3B | 1.27B | 1.45B |
| Property, Plant & Equipment | 27.25M | 80.47M | 78.87M | 83.37M | 77.35M | 70.05M | 58.65M | 55.69M |
| Fixed Asset Turnover | 46.00x | 17.20x | 18.96x | 20.14x | 23.11x | 27.06x | 34.52x | 43.69x |
| Goodwill | 1.23B | 1.23B | 1.32B | 1.84B | 1.16B | 1.05B | 1.05B | 1.12B |
| Intangible Assets | 53.34M | 54.3M | 73.57M | 102.85M | 95.86M | 94.01M | 89.57M | 92.56M |
| Long-Term Investments | 21.74M | 0 | 0 | 0 | 0 | 74.81M | 60.63M | 0 |
| Other Non-Current Assets | 8.27M | 30.35M | 31.62M | 33.36M | 109.11M | 4.67M | 7.33M | 45.72M |
| Total Assets | 1.55B▲ 0% | 1.58B▲ 1.8% | 1.84B▲ 16.8% | 2.33B▲ 26.6% | 1.71B▼ 26.7% | 1.61B▼ 5.8% | 1.66B▲ 3.1% | 2.01B▲ 21.0% |
| Asset Turnover | 0.81x | 0.88x | 0.81x | 0.72x | 1.04x | 1.17x | 1.22x | 1.21x |
| Asset Growth % | - | 1.77% | 16.83% | 26.59% | -26.67% | -5.77% | 3.13% | 20.98% |
| Total Current Liabilities | 198.36M | 168.54M | 260.41M | 344.83M | 326.5M | 354.76M | 402.17M | 424.46M |
| Accounts Payable | 0 | 66.42M | 56.67M | 52.62M | 44.62M | 30.13M | 36.44M | 0 |
| Days Payables Outstanding | - | 25.13 | 19.88 | 16.91 | 13.19 | 8.46 | 9.57 | - |
| Short-Term Debt | 9.4M | 10.09M | 12.78M | 13.71M | 15.38M | 168.16M | 183.1M | 29.26M |
| Deferred Revenue (Current) | -37.99M | 0 | 29.44M | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 113.97M | 20.74M | 54.89M | 174.37M | 181.26M | 42.24M | 38.65M | 395.19M |
| Current Ratio | 1.08x | 1.11x | 1.31x | 0.81x | 0.83x | 0.89x | 0.98x | 1.32x |
| Quick Ratio | 1.08x | 1.11x | 1.31x | 0.81x | 0.83x | 0.89x | 0.98x | 1.32x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.01B | 1.14B | 1.32B | 1.35B | 1.39B | 1.39B | 1.38B | 1.39B |
| Long-Term Debt | 954.73M | 1.02B | 1.16B | 1.23B | 1.28B | 1.28B | 1.27B | 1.31B |
| Capital Lease Obligations | 0 | 41.22M | 40.25M | 44.68M | 45.82M | 39.82M | 31.72M | 0 |
| Deferred Tax Liabilities | 1.75M | 1.75M | 27.41M | 3.05M | 3.84M | 4.86M | 5.89M | 0 |
| Other Non-Current Liabilities | 52.86M | 78.42M | 85.28M | 77.34M | 58.69M | 64.64M | 74.05M | 78.67M |
| Total Liabilities | 1.21B | 1.31B | 1.58B | 1.7B | 1.72B | 1.74B | 1.79B | 1.82B |
| Total Debt | 952.44M | 1.08B | 1.23B | 1.3B | 1.36B | 1.5B | 1.5B | 1.34B |
| Net Debt | 944.44M | 1.08B | 1.09B | 1.27B | 1.34B | 1.46B | 1.42B | 1.15B |
| Debt / Equity | 2.76x | 3.98x | 4.60x | 2.04x | - | - | - | 6.91x |
| Debt / EBITDA | 18.69x | 16.37x | 45.94x | - | - | 39.28x | 8.79x | 4.65x |
| Net Debt / EBITDA | 18.53x | 16.32x | 40.81x | - | - | 38.13x | 8.29x | 3.98x |
| Interest Coverage | 0.52x | 0.42x | -0.04x | -0.52x | -5.96x | 0.05x | 0.89x | 1.89x |
| Total Equity | 344.99M▲ 0% | 270.94M▼ 21.5% | 267.17M▼ 1.4% | 637.95M▲ 138.8% | -4.17M▼ 100.7% | -127.44M▼ 2952.3% | -122.09M▲ 4.2% | 194.46M▲ 259.3% |
| Equity Growth % | - | -21.46% | -1.39% | 138.78% | -100.65% | -2952.34% | 4.19% | 259.28% |
| Book Value per Share | 1.91 | 1.46 | 1.44 | 3.45 | -0.02 | -0.67 | -0.63 | 0.90 |
| Total Shareholders' Equity | 344.99M | 270.94M | 267.17M | 637.95M | -4.17M | -127.44M | -122.09M | 194.46M |
| Common Stock | 66K | 1.37M | 1.42M | 1.85M | 1.89M | 1.91M | 1.93M | 0 |
| Retained Earnings | -323.83M | -400.58M | -457.63M | -574.68M | -1.24B | -1.37B | -1.38B | -1.16B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 2.13M | 1.46M | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
AVAH Cash Flow Statement
Aveanna Healthcare Holdings Inc. (AVAH) cash flow — operating, investing & free cash flow history
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Jan'26 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 21.6M | -8.71M | 116.62M | -11.35M | -48.4M | 22.67M | 32.64M | 125.86M |
| Operating CF Margin % | 1.72% | -0.63% | 7.8% | -0.68% | -2.71% | 1.2% | 1.61% | 5.17% |
| Operating CF Growth % | - | -140.35% | 1438.28% | -109.73% | -326.45% | 146.84% | 43.95% | 285.63% |
| Net Income | -47.15M | -76.52M | -57.05M | -117.04M | -662.03M | -134.52M | -10.93M | 225.03M |
| Depreciation & Amortization | 11.94M | 27.01M | 30.22M | 35.39M | 38.82M | 30.1M | 31.16M | 0 |
| Stock-Based Compensation | 2.12M | 1.95M | 3.27M | 14.43M | 15.89M | 13.16M | 17.46M | 0 |
| Deferred Taxes | -3.63M | -919K | -6.42M | 1.31M | -115K | 1.01M | 1.03M | 0 |
| Other Non-Cash Items | 23.56M | 26.7M | 90.06M | 125.89M | 601.26M | 136.32M | 23.87M | -99.18M |
| Working Capital Changes | 34.76M | 13.06M | 56.54M | -71.33M | -42.22M | -23.4M | -29.97M | 0 |
| Change in Receivables | -7.96M | 3.34M | 8.56M | -8.81M | -3.23M | -15.32M | -28.64M | 0 |
| Change in Inventory | 15.4M | -13.2M | 0 | -27.06M | 0 | 0 | 0 | 0 |
| Change in Payables | 21.51M | 19.29M | -6.81M | -11.7M | -3.92M | -13.92M | 6.45M | 0 |
| Cash from Investing | -229.55M | -17.82M | -193.54M | -681.83M | -25.29M | -8.79M | -6.32M | -22.3M |
| Capital Expenditures | -19.58M | -16.64M | -15.24M | -15.95M | -12.01M | -6.12M | -6.32M | -7.45M |
| CapEx % of Revenue | 1.56% | 1.2% | 1.02% | 0.95% | 0.67% | 0.32% | 0.31% | 0.31% |
| Acquisitions | -209.97M | -1.19M | -178.31M | -666.91M | -1.55M | 0 | 0 | -14.85M |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | -11.27M | -2.68M | 0 | 0 |
| Cash from Financing | 204.15M | 21.86M | 210.94M | 586.33M | 62.42M | 10.85M | 14.03M | 5.41M |
| Debt Issued (Net) | 149.73M | 68.94M | 136.69M | 161.59M | 60.15M | -5.73M | -2.36M | 0 |
| Equity Issued (Net) | 1000K | 0 | 1000K | 1000K | 1000K | 945K | 1000K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -47.07M | 24.25M | -52.95M | -1.74M | 15.63M | 13.3M | 5.41M |
| Net Change in Cash | -3.8M▲ 0% | -4.67M▼ 23.1% | 134.02M▲ 2967.3% | -106.86M▼ 179.7% | -11.27M▲ 89.5% | 24.73M▲ 319.3% | 40.35M▲ 63.2% | 108.97M▲ 170.1% |
| Free Cash Flow | 2.02M▲ 0% | -25.35M▼ 1356.9% | 101.38M▲ 499.9% | -27.3M▼ 126.9% | -60.41M▼ 121.3% | 16.56M▲ 127.4% | 26.32M▲ 59.0% | 125.86M▲ 378.2% |
| FCF Margin % | 0.16% | -1.83% | 6.78% | -1.63% | -3.38% | 0.87% | 1.3% | 5.17% |
| FCF Growth % | - | -1356.87% | 499.91% | -126.93% | -121.3% | 127.4% | 58.96% | 378.22% |
| FCF per Share | 0.01 | -0.14 | 0.55 | -0.15 | -0.33 | 0.09 | 0.14 | 0.59 |
| FCF Conversion (FCF/Net Income) | -0.46x | 0.11x | -2.04x | 0.10x | 0.07x | -0.17x | -2.99x | 0.56x |
| Interest Paid | 62.77M | 92.81M | 73.05M | 58.96M | 102.53M | 137.85M | 152.51M | 0 |
| Taxes Paid | 3.15M | 1.55M | 2.17M | 5.28M | 1.59M | 1.14M | 5.71M | 0 |
AVAH Key Ratios
Aveanna Healthcare Holdings Inc. (AVAH) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -13.67% | -24.85% | -21.2% | -25.86% | -208.92% | - | - | 621.89% |
| Return on Invested Capital (ROIC) | 2.27% | 2.22% | -0.19% | -1.66% | -29.75% | 0.46% | 7.99% | 15.08% |
| Gross Margin | 31.45% | 30.29% | 30.4% | 32.31% | 30.95% | 31.42% | 31.39% | 33.09% |
| Net Margin | -3.76% | -5.53% | -3.82% | -6.97% | -37.03% | -7.1% | -0.54% | 9.25% |
| Debt / Equity | 2.76x | 3.98x | 4.60x | 2.04x | - | - | - | 6.91x |
| Interest Coverage | 0.52x | 0.42x | -0.04x | -0.52x | -5.96x | 0.05x | 0.89x | 1.89x |
| FCF Conversion | -0.46x | 0.11x | -2.04x | 0.10x | 0.07x | -0.17x | -2.99x | 0.56x |
| Revenue Growth | - | 10.4% | 8.02% | 12.27% | 6.49% | 6.02% | 6.82% | 20.19% |
AVAH SEC Filings & Documents
Aveanna Healthcare Holdings Inc. (AVAH) SEC filings — annual & quarterly reports (10-K, 10-Q)
AVAH Frequently Asked Questions
Aveanna Healthcare Holdings Inc. (AVAH) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Aveanna Healthcare Holdings Inc. (AVAH) reported $2.43B in revenue for fiscal year 2025. This represents a 94% increase from $1.25B in 2018.
Aveanna Healthcare Holdings Inc. (AVAH) grew revenue by 20.2% over the past year. This is strong growth.
Yes, Aveanna Healthcare Holdings Inc. (AVAH) is profitable, generating $225.0M in net income for fiscal year 2025 (9.2% net margin).
Dividend & Returns
Aveanna Healthcare Holdings Inc. (AVAH) has a return on equity (ROE) of 621.9%. This is excellent, indicating efficient use of shareholder capital.
Aveanna Healthcare Holdings Inc. (AVAH) generated $125.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More AVAH
Aveanna Healthcare Holdings Inc. (AVAH) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates